{
  "id": 4083,
  "language": "english",
  "hallucination": "yes",
  "ground_truth_source": "Original_text",
  "dialogue_data": {
    "dialogue_metadata": {
      "inferred_relationship": "Co-hosts",
      "inferred_vibe": "Informative"
    },
    "dialogue_turns": [
      {
        "speaker": "HostA",
        "text": "Thirty-one percent reduction in HIV risk from that Ad5 vector vaccine trial over a decade ago.",
        "tts_text": "Thirty-one percent reduction in H I V risk from that Ad5 vector vaccine trial over a decade ago.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "The researchers warn of a cautionary tale from efforts to create an HIV vaccine over a decade ago, where a promising vaccine candidate actually increased the risk of some men catching the virus.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "Right, that was a huge deal at the time, but it's uh, it's complicated because of the adenovirus 5 vector they used.",
        "tts_text": "Right, that was a huge deal at the time, but it's uh, it's complicated because of the adenovirus five vector they used.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "The vaccine made use of a modified virus called adenovirus 5 (Ad5) as a vector to transport some of HIVs genetic material into the body.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "Yeah, and now we're seeing Ad5 pop up again with some COVID-19 vaccine candidates, which is making researchers nervous given the HIV link.",
        "tts_text": "Yeah, and now we're seeing Ad5 pop up again with some COVIDminus nineteen vaccine candidates, which is making researchers nervous given the H I V link.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "Ad5 is used as a vector in some Covid-19 vaccines Science identifies four such candidates that are currently undergoing clinical trials in various countries around the world, including the U.S., with two in large scale phase 3 trials ongoing in Russia and Pakistan.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "Exactly. Dr. Anthony Fauci was actually a lead critic of the WHO recommendation to use Ad5 widely back then, which is interesting.",
        "tts_text": "Exactly. Dr. Anthony Fauci was actually a lead critic of the W H O recommendation to use Ad5 widely back then, which is interesting.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "Exactly how the vaccine increased the risks of HIV transmission is unknown, but a conference convened by the National Institutes of Health recommended against further use of Ad5 as a vector in HIV vaccines (Dr. Anthony Fauci was lead author of the paper outlining this position.)",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "Mhm, and the authors of this newer paper went private with their concerns because COVID Ad5 vaccines are being used in low-HIV prevalence areas.",
        "tts_text": "Mhm, and the authors of this newer paper went private with their concerns because COVID Ad5 vaccines are being used in low-H I V prevalence areas.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "The authors said they went public because Ad5 vaccines for Covid-19 might soon be tested in populations with high HIV prevalence.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "But like, Lawrence Corey from the WHO said he'd support it in high-income countries since there aren't many other options right now.",
        "tts_text": "But like, Lawrence Corey from the W H O said he'd support it in high-income countries since there aren't many other options right now.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "Lawrence Corey, one of the authors who now co-leads the Covid-19 prevention network in the U.S. that is testing vaccines on behalf of the NIH, told Science that if he were in a sub-Saharan African country, where theres a high prevalence of HIV, I dont see why I would pick an Ad5 vector (vaccine) when there are many other alternative choices.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "Still, the informed consent documents should probably mention the existing risks, even if they're downplayed.",
        "tts_text": "Still, the informed consent documents should probably mention the existing risks, even if they're downplayed.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "The researchers stressed the need to understand the role Ad5 might play in increasing the risks of HIV in vulnerable populations before developing and deploying vaccines using the vector, adding that informed consent documents should reflect the considerable literature on the risk of HIV acquisition with Ad5 vectors.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "For sure. It's a tough balance between urgency and safety, especially with vulnerable populations.",
        "tts_text": "For sure. It's a tough balance between urgency and safety, especially with vulnerable populations.",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": "",
        "confidence": 0.0
      },
      {
        "speaker": "HostA",
        "text": "And it's worth noting that none of the major COVID vaccines, like Pfizer or Moderna, actually use Ad5 vectors.",
        "tts_text": "And it's worth noting that none of the major COVID vaccines, like Pfizer or Moderna, actually use Ad5 vectors.",
        "check_worthy": true,
        "factual_label": "NEI",
        "evidence_snippet": "",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "Right, that's an important clarification—this is more about candidates in development or use elsewhere.",
        "tts_text": "Right, that's an important clarification-this is more about candidates in development or use elsewhere.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "Ad5 is used as a vector in some Covid-19 vaccines Science identifies four such candidates that are currently undergoing clinical trials in various countries around the world, including the U.S., with two in large scale phase 3 trials ongoing in Russia and Pakistan.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "So the concern is really about future vaccines or those rolling out in certain regions without full transparency.",
        "tts_text": "So the concern is really about future vaccines or those rolling out in certain regions without full transparency.",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": "",
        "confidence": 0.0
      },
      {
        "speaker": "HostB",
        "text": "Yeah, and given the history with HIV, it's something we really can't ignore.",
        "tts_text": "Yeah, and given the history with H I V, it's something we really can't ignore.",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": "",
        "confidence": 0.0
      }
    ]
  },
  "generator_model": "DeepSeek-V3.1",
  "batch_index": 2,
  "artist_script": "Thirty-one percent reduction in HIV risk from that Ad5 vector vaccine trial over a decade ago.\nHostB: Right, that was a huge deal at the time, but it’s uh, it’s complicated because of the adenovirus 5 vector they used.\nHostA: Yeah, and now we’re seeing Ad5 pop up again with some COVID-19 vaccine candidates, which is making researchers nervous given the HIV link.\nHostB: Exactly. Dr. Anthony Fauci was actually a lead critic of the WHO recommendation to use Ad5 widely back then, which is interesting.\nHostA: Mhm, and the authors of this newer paper went private with their concerns because COVID Ad5 vaccines are being used in low-HIV prevalence areas.\nHostB: But like, Lawrence Corey from the WHO said he’d support it in high-income countries since there aren’t many other options right now.\nHostA: Still, the informed consent documents should probably mention the existing risks, even if they’re downplayed.\nHostB: For sure. It’s a tough balance between urgency and safety, especially with vulnerable populations.\nHostA: And it’s worth noting that none of the major COVID vaccines, like Pfizer or Moderna, actually use Ad5 vectors.\nHostB: Right, that’s an important clarification—this is more about candidates in development or use elsewhere.\nHostA: So the concern is really about future vaccines or those rolling out in certain regions without full transparency.\nHostB: Yeah, and given the history with HIV, it’s something we really can’t ignore."
}